Novartis – Fake news?
The news hit in early May 2018: The international press had a field day. „The general counsel for Swiss drugmaker Novartis has resigned, th... »
-
-
-
-
-
-
-
-
-
-
Slide #23
-
Slide #24
-
-
Latest Articles
formerly known as
Thanks to Lucas Hässig, Switzerland’s Journalist of the year 2018 for this story. This was one of Vasant Narasimhan first tests of leadership as a... »
Suffern strange deal
We raised a question at last year’s Novartis AGM, and have not yet found a satisfactory answer as to who profited by $12 million from a most peculiar pro... »
Sandoz – Mixed Messages?
At the Forbes Healthcare Summit in New York in November 2018, Vasant Narasimhan, CEO of Novartis explained how his strategy is to narrow his focus... »
Credit Suisse – Messy House?
A few years ago Credit Suisse sent me a final DEMAND letter threatening dire consequences if I did not settle my outstanding balance. They already blocke... »
Novartis – Jean-Therapy Breakthrough
An INSEAD alumni meeting was held on 29 November 2018, on the Novartis campus in Basel. INSEAD for those not familiar, is a leading graduate business sch... »
